Sleeping Aid Market

Sleeping Aid Market Study by Drugs and Devices for Insomnia, Sleep Deprivation, Narcolepsy, and Sleep Apnea from 2024 to 2034

Analysis of Sleeping Aid Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

Sleeping Aid Market Outlook (2024 to 2034)

The global sleeping aid market size is projected to reach a valuation of US$ 48.04 billion by the end of 2034, up from US$ 29.88 billion in 2024. Worldwide revenue from the sales of sleeping aids has been projected to increase at 4.9% CAGR from 2024 to 2034.

Sleep disorders affect the sleep cycle or disturb restful sleep, which can lead to daytime tiredness and other symptoms. Persistent sleep disorders result in daytime fatigue despite getting at least seven hours of sleep the night before and a diminished or impaired capacity to engage in routine daytime activities. Insomnia, narcolepsy, restless legs syndrome, and sleep apnea are some of the common sleep disorders.

Lack of sleep can have negative effects on academic and professional performance, interpersonal interactions, thinking, mental health, and weight, and also lead to the onset of diabetes and heart disease. Sleep disorders can be treated with natural sleep remedies using natural or herbal sleeping tablets, and also with homeopathic sleep remedies.

Key Market Growth Drivers

  • Production of sleeping aids is increasing in developing countries, thus driving sleeping aid market growth.
  • Increasing elderly population and prevalence of obesity are contributing to a rise in sleep problems and fueling demand for sleeping aids.
  • Global demand for sleeping aids is driven by the growing patient population with cardiovascular diseases, respiratory issues, and obstructive sleep apnea.
  • Treatment options for sleep disturbances encompass psychotherapy, medications, supplements, and wakefulness-promoting pharmaceuticals.
  • Sleep apnea devices such as continuous positive airway pressure (CPAP) devices are gaining popularity for treating sleep-related disorders.
  • Key sleeping aid manufacturers are introducing a variety of pills, incorporating ingredients like chamomile, hops, L-theanine, and melatonin, to meet the increasing demand.
  • Increased awareness of the benefits of adequate sleep is driving demand for sleeping aid products.
  • Key sleeping aid market trends that manufacturers are capitalizing on include rising product approvals, government support for improved therapeutic approaches, and advancements in sleep apnea testing.
Report Attributes Details
Sleeping Aid Market Size (2024E) US$ 29.88 Billion
Forecasted Market Value (2034F) US$ 48.04 Billion
Global Market Growth Rate (2024 to 2034) 4.9% CAGR
North America Market Share (2024E) 38%
East Asia Market Value (2034F) US$ 8.84 Billion
Sales of Sleeping Aid Drugs (2024E) US$ 5.5 Billion
Insomnia Segment Market Value (2034F) US$ 13.17 Billion
Hospitals Segment Market Value (2034F) US$ 7.02 Billion
Key Companies Profiled
  • Pfizer Inc.
  • Koninklijke Philips N.V.
  • Merck & Co. Inc.
  • Fisher & Paykel Healthcare Limited
  • Compumedics Ltd.
  • Abecca Healthcare
  • Betterlifehealthcare Ltd.
  • Lifeline Corporation Pte Ltd.
  • Compumedics Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • ResMed Inc.
  • Cadwell Industries, Inc.
  • Sanofi SA
  • GlaxoSmithKline Plc.
  • Hill-Rom Holdings, Inc.
  • Drive DeVilbiss Healthcare LLC
  • Natus Medical, Inc.

Don't Need a Global Report?

save 40%! on Country & Region specific reports

What are the Opportunities on Offer for Sleeping Aid Manufacturers?

“Increase in Prevalence of Sleep Disorders and Innovation in Healthcare”

Altered sleep patterns brought on by lifestyle changes, easier access to medical services, and an increase in demand for high-quality healthcare are all factors generating opportunities for sleeping aid manufacturers. Several opportunities are opening up for suppliers of sleeping aid devices to address chronic sleep problems and enhance their market share.

Some other factors contributing to the increase in the sleeping aid market size include a focus on the expansion of healthcare infrastructure, widespread use of portable sleep apnea treatment equipment, rising geriatric population, increasing adoption of wearable sensors and monitors, and the pervasive burden of obstructive sleep apnea (OSA) and insomnia.

  • May 2019 saw the successful completion of a phase-3 trial for insomnia treatment in patients with mild-to-moderate Alzheimer's disease and dementia using Merck's BELSOMRA (suvorexant) C-IV.

“Rising Awareness of Importance of Quality Sleep for Mental and Physical Well-being”

High quality of life and optimal physical and mental health depend on sufficient sleep. In today's 24/7 culture, inadequate sleep is a common issue with significant negative implications for health. Studies highlight the link between sleep deprivation and both physical and mental well-being.

Insufficient sleep is linked to workplace errors and car accidents, resulting in several injuries and disabilities annually. Adequate sleep is vital for maintaining overall health. Sleep problems elevate an individual's risk of health issues. Consequently, the demand for sleeping aids is on the rise.

Which Factors are Affecting Sales Growth of Sleeping Aids?

“Risk of Side Effects from Sleeping Aids and Wide Availability of Alternative Treatments”

Concerns about the complexity of treating sleep problems are growing with the introduction of new technologies. Furthermore, inadequate equipment standards for sleeping aid machines and insufficient documentation for the use and licensing of sleeping tablets are slowing down market growth. Common adverse reactions to sleeping aids include headaches, prolonged drowsiness, memory and performance issues during the day, and allergic reactions. The availability of alternative medications and treatments like circadian rhythm sleep therapy for conditions like narcolepsy and insomnia presents are also impediments to market growth.

More Insights, Lesser Cost (-50% off)

Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR

Country-wise Insights

North America accounts for a sizeable share of the global market for sleeping aids due to the focus of important industry players on innovation as well as rising consumer awareness about sleep quality and sleeping aid products. The market in East Asia is projected to expand at an impressive CAGR of 7.1% through 2034.

Why is the United States a Lucrative Market for Sleeping Aid Producers?

“Growing Awareness of Benefits of Sleeping Aid Products”

Attribute United States
Market Value (2024E) US$ 9.62 Billion
Growth Rate (2024 to 2034) 4.2% CAGR
Projected Value (2034F) US$ 14.46 Billion

The need for relevant sleeping aids is increasing as sleep disorders are becoming more common in the United States. The country is estimated to hold 84.7% sleeping aid market share in North America in 2024. Rising awareness of the benefits of sleeping aids is also contributing to their extensive adoption. The presence of some important market participants such as Merck and Pfizer in the nation is contributing to revenue growth.

Which Trends in China are Sleeping Aid Manufacturers Exploiting?

“Rising Prevalence of Insomnia among Younger Generation”

Attribute China
Market Value (2024E) US$ 1.8 Billion
Growth Rate (2024 to 2034) 7% CAGR
Projected Value (2034F) US$ 3.6 Billion

The healthcare sector in China is exhibiting significant growth due to several factors such as the increasing number of hospitals equipped with modern facilities, advancements in sleeping aid technology, and the rising prevalence of insomnia among the younger demographic. Lifestyle changes are also playing a pivotal role in driving market expansion. The increasing elderly and obese population in China is projected to boost the demand for sleeping drugs and gadgets.

Category-wise Insights

By product type, revenue from the sales of sleeping aid drugs is estimated at US$ 5.51 billion in 2024. Demand for sleeping aid products for the treatment of insomnia patients is estimated to expand at a 4.8% CAGR from 2024 to 2034

Which Condition Accounts for High Use of Sleeping Aids?

“Increased Demand for Sleeping Aids in Management of Sleep Apnea”

Attribute Sleep Apnea
Segment Value (2024E) US$ 8.91 Billion
Growth Rate (2024 to 2034) 5.1% CAGR
Projected Value (2034F) US$ 14.69 Billion

Sleep apnea is a sleep disorder characterized by irregular breathing patterns during sleep. Chronic sleep apnea results in insufficient oxygen supply to the brain and other organs, leading to irregular breathing during sleep. Elderly individuals and those with conditions like hypertension, diabetes, and cardiovascular disorders are more prone to such conditions. Obstructive sleep apnea is the most prevalent type globally, and it necessitates early detection and treatment with sleeping aid products like drugs and devices.

What are the Advantages Offered by e-Commerce for Sleeping Aid Product Distribution?

“Enhanced Accessibility to Product Information and Discount Offerings”

Attribute e-Commerce
Segment Value (2024E) US$ 6.37 Billion
Growth Rate (2024 to 2034) 5.1% CAGR
Projected Value (2034F) US$ 10.44 Billion

By distribution channel, e-commerce is expected to account for 21.3% of the global market share in 2024. Through e-commerce platforms, consumers obtain all the information related to a product with its advantages and disadvantages. Also, it is an easy, comfortable, and more convenient option to purchase sleeping aids. Additionally, some e-commerce platforms offer discounts on sleeping aid products, and this reason is making it a preferred choice for budget-conscious consumers. e-Commerce platforms are also helping consumers share their personal information and giving them access to useful information.

Know thy Competitors

Competitive landscape highlights only certain players
Complete list available upon request

Competitive Landscape

Key players in the sleeping aid market include Pfizer Inc., Koninklijke Philips N.V., Merck & Co. Inc., Fisher & Paykel Healthcare Limited, Compumedics Ltd., Abecca Healthcare, Betterlifehealthcare Ltd., Lifeline Corporation Pte Ltd, Compumedics Ltd., and Teva Pharmaceutical Industries Ltd.

  • In April 2024, Hostage Tape, a top sleeping aid manufacturer, and UFC, the top mixed martial arts organization in the world, announced a marketing agreement aimed at promoting the Hostage Tape brand across key assets of UFC.
  • According to CNN Health, in April 2023, a study discovered that some of the over two dozen melatonin gummies marketed as sleeping aids in the United States had potentially harmful levels of the hormone that aids in sleep regulation.

Segmentation of Sleeping Aid Market Research

  • By Product :

    • Drugs
      • Insomnia Treatment Drugs
        • Doxepin Hydrochloride
        • Eszopiclone
        • Ramelteon
        • Triazolam
        • Zaleplon
        • Quazepam
      • Narcolepsy Treatment Drugs
        • Modafinil
        • Sodium Oxybate
        • Armodafinil
    • Devices
      • CPAP Devices
      • BiPAP Devices
      • APAP Devices
    • Others
      • Mattresses & Pillows
      • Chin Straps
      • Mouth Pieces & Nasal Devices
  • By Indication :

    • Insomnia
    • Sleep Deprivation
    • Narcolepsy
    • Sleep Apnea
  • By Distribution Channel :

    • Hospital Pharmacies
    • Retail Pharmacies
    • e-Commerce
    • Drug Stores
  • By Region :

    • North America
    • Europe
    • Latin America
    • East Asia
    • South Asia & Oceania
    • Middle East & Africa

- FAQs -

How big is the sleeping aid market in 2024?

The global market for sleeping aids is estimated at US$ 29.88 billion in 2024.

At what rate is the demand for sleeping aids projected to rise?

Sales of sleeping aids are forecasted to increase at 4.9% CAGR through 2034.

What is the demand projection for the global market by 2034?

The market has been forecasted to reach US$ 48.04 billion by 2034-end.

Which product type holds a significant market share of sleeping aids?

Sleeping aid drugs are projected to occupy a market share of 18.4% in 2024.

At what rate is the market forecasted to expand in Japan?

The market in Japan is projected to expand at a CAGR of 7.1% through 2034.

Who are the leading manufacturers of sleeping aids?

Key producers of sleeping aid products include Pfizer Inc., Fisher & Paykel Healthcare Limited, and Abecca Healthcare.

- Also of Interest -

Insomnia Treatment Market

Insomnia Treatment Market Study by OTC Drugs and Prescription Drugs Sold through Hospital Pharmacies, Retail Pharmacies, e-Commerce, Drug Stores, and Hypermarkets 2024 to 2034

Sleep Mask Market

Sleep Mask Market Analysis by Regular, Contoured, and Wrap Around for Men and Women from 2023 to 2033

Circadian Rhythm Sleep Treatment Market

Circadian Rhythm Sleep Treatment Market Study by Devices, Medications, and Chronotherapy from 2024 to 2034

Sleeping Aid Market

Schedule a Call